Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > Next Week's Option Expiry

<< Previous

Bullboard Posts

Next >>

Comment by palinc2000on Dec 14, 2022 10:13am

134 Views

Post# 35170692

RE:RE:Next Week's Option Expiry

Come to think of it I dont think there are any SEC regulations preventing options that are about to expire to be exercised during the black out period...Recall that last year a massive amount of options were granred on DEC 1 the first day of the black out period,,,,1 am puzzled as to the why!!!!!
Can you provide the link ?

palinc2000 wrote:
I guess that would mean sometimes in February.
The tax liability if any would be differed to April 2024

SABBOBCAT wrote: FYI: due to being in blackout period, the option expiry has been extended until 10 days after the blackout period ends.